Hans H. Maurer

Hans H. Maurer

Auto-generated profile, based on publicly available information

Hans H. Maurer

Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, Saarland University, Homburg (Saar), Germany

Research Focus & Metrics

Academic Career Length

46Years (1981-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2010 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Closed access
PDF file
MMMarkus R. Meyer
Markus R. Meyer
JWJens Wilhelm
Jens Wilhelm
FPFrank T. Peters
Frank T. Peters
HMHans H. Maurer
Hans H. Maurer

22 March 2007 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Closed access
PDF file
HMHans H. Maurer
Hans H. Maurer

1 November 2002 in Accreditation and Quality Assurance
Verified
Journal Article
Closed access
PDF file
FPFrank T. Peters
Frank T. Peters
HMHans H. Maurer
Hans H. Maurer

1 September 1992 in Journal of Chromatography B: Biomedical Sciences and Applications
Verified
Journal Article
Closed access
HMHans H. Maurer
Hans H. Maurer

1 August 1998 in Journal of Chromatography B: Biomedical Sciences and Applications
Verified
Journal Article
Closed access
HMHans H. Maurer
Hans H. Maurer

1 April 2002 in Therapeutic Drug Monitoring
Verified
Journal Article
Closed access
TKThomas Kraemer
Thomas Kraemer
HMHans H. Maurer
Hans H. Maurer
This paper reviews the toxicokinetics of amphetamines. The designer drugs MDA (methylenedioxy-amphetamine, R,S-1-(3´,4´-methylenedioxyphenyl)2-propanamine), MDMA (R,S-methylenedioxymethamphetamine), and MDE (R,S-methylenedioxyethylamphetamine), as well as BDB (benzodioxolylbutanamine;R,S-1-(1´,3´-benzodioxol-5´-yl)-2-butanamine or R,S- 1-(3´,4´-methylenedioxyphenyl)-2-butanamine) and MBDB (R,S-N-methyl-benzodioxolylbutanamine), were taken into consideration, as were the following N-alkylated amphetamine derivatives: amphetaminil, benzphetamine, clobenzorex, dimethylamphetamine, ethylamphetamine, famprofazone, fencamine, fenethylline, fenproporex, furfenorex, mefenorex, mesocarb, methamphetamine, prenylamine, and selegiline. English-language publications from 1995 to 2000 were reviewed. Papers describing identification of metabolites or cytochrome P450 isoenzyme-dependent metabolism and papers containing pharmacokinetic/toxicokinetic data were considered and summarized. The implications of toxicokinetics for toxicologic assessment or for interpretation in forensic cases are discussed.